New leadership to accelerate healthcare sector growth

Asahi Kasei has named Ken Shinomiya as the new leader of its Healthcare Sector, following Richard Packer’s tenure. Shinomiya, previously President of Asahi Kasei Life Science, brings a wealth of experience and a strategic vision for advancing the company’s healthcare portfolio. Under his leadership, Asahi Kasei aims to accelerate its global growth in pharmaceuticals, life sciences, and critical care, further enhancing its commitment to improving patient outcomes worldwide.

Shinomiya's journey in the healthcare industry includes significant roles, such as Vice President of Strategy at ZOLL Medical and Head of the Bioprocess Division at Asahi Kasei Medical. He became President of Asahi Kasei Medical in 2023, and later President of Asahi Kasei Life Science, where he led the expansion of the company’s life sciences business. This included the addition of essential services like contract research and biologics development, as well as the acquisition of Bionova Scientific in the US.

Asahi Kasei’s Healthcare Sector has seen significant globalisation, particularly since its acquisition of ZOLL Medical in 2012, which established a strong presence in the U.S. critical care market. The sector’s continued global expansion is supported by targeted investments, including mergers and acquisitions, and strategic moves like the relocation of the company’s headquarters to the US in 2023.

With Shinomiya at the helm, Asahi Kasei’s Healthcare Sector is poised to continue its long-term growth strategy, aiming for operating income of ¥150 billion by 2030. “Our healthcare business exemplifies Asahi Kasei’s unique ability to integrate innovation with global operations,” said Shinomiya. “We will continue evolving with a global perspective to drive growth and enhance patient care worldwide.”

More information online